This resource is part of our Treatment Navigator, a comprehensive guide to common behavioral/mental health diagnoses and the evidence based practices (EBPs) that help these conditions.
Overview
Persistent Depressive Disorder (PDD), formerly known as dysthymia, is characterized by a chronic depressed mood lasting for at least two years in adults (or one year in children and adolescents), accompanied by symptoms such as low energy, poor concentration, hopelessness, low self-esteem, and changes in sleep or appetite. Although the symptoms are often less severe than those seen in Major Depressive Disorder (MDD), their chronic nature leads to significant distress and functional impairment. Many individuals experience periods of “double depression,” where major depressive episodes occur on top of a persistent low mood. Treatment emphasizes behavioral activation, cognitive restructuring, and long-term skills to prevent relapse and improve quality of life.
Indicated Evidence-Based Practices (EBPs)
- Cognitive Behavioral Therapy (CBT) – targets chronic negative thinking, hopelessness, and behavioral avoidance; strong evidence base for PDD
- Cognitive Behavioral Analysis System of Psychotherapy (CBASP) – developed specifically for chronic depression; focuses on interpersonal patterns and situational analysis
- Behavioral Activation (BA) – emphasizes re-engagement with rewarding and value-driven activities to counter anhedonia
- Mindfulness-Based Cognitive Therapy (MBCT) – supports relapse prevention by enhancing awareness of negative thought patterns and emotional regulation
- Interpersonal Psychotherapy (IPT) for Chronic Depression – focuses on relational issues, role transitions, and interpersonal loss
- Schema Therapy (ST) – addresses entrenched maladaptive schemas contributing to chronic low mood and relational difficulties
- Pharmacotherapy – SSRIs, SNRIs, or atypical antidepressants are often combined with psychotherapy for optimal outcomes
When to Choose What
CBT and CBASP are first-line treatments for PDD, both demonstrating strong efficacy in chronic depressive conditions.
CBASP is particularly effective for individuals with early-onset, trauma-related, or interpersonally avoidant depression.
BA may be prioritized for clients struggling with inactivity, anhedonia, or lack of structure.
IPT or Schema Therapy may be useful when relational dysfunction or early attachment patterns perpetuate low mood.
MBCT is best suited for maintenance and relapse prevention once acute symptoms are stabilized.
Combined treatment with antidepressant medication and psychotherapy yields higher remission rates than either modality alone (Keller et al., 2000).
Core Components of Treatment
- Psychoeducation about chronic depression, emotional patterns, and treatment expectations
- Cognitive restructuring to challenge pessimism, self-criticism, and helplessness
- Behavioral activation and activity scheduling to increase exposure to positive reinforcement
- Interpersonal mapping to identify recurring relational problems and unhelpful interaction cycles (CBASP focus)
- Development of problem-solving and emotion regulation skills
- Identification and modification of long-standing core beliefs and schemas
- Relapse prevention planning, including ongoing self-monitoring and maintenance of activity routines
- Coordination with medical providers to monitor pharmacotherapy, side effects, and progress
Measures and Monitoring
Screening and diagnostic tools
- Patient Health Questionnaire-9 (PHQ-9): brief measure for depressive symptom severity and treatment tracking
- Hamilton Depression Rating Scale (HAM-D): clinician-rated assessment for chronic or treatment-resistant depression
- Beck Depression Inventory-II (BDI-II): self-report tool for cognitive and affective symptoms
- Inventory of Depressive Symptomatology (IDS-C or IDS-SR): sensitive to changes over time
- SCID-5 or MINI mood disorder modules: structured diagnostic confirmation and distinction from MDD or cyclothymia
Monitoring and outcome tools
- PHQ-9 or BDI-II administered every 3–4 sessions to track symptom changes
- Behavioral activation logs to measure engagement with valued activities
- WHO-5 Well-Being Index or Recovery Assessment Scale for wellbeing gains
- Session Rating Scale (SRS) to monitor alliance and therapy engagement
- Relapse monitoring checklists for early detection of symptom recurrence
Adaptations and Special Considerations
Chronicity and identity: Many clients experience depression as part of their self-concept; treatment should help separate identity from illness.
Therapeutic pacing: Progress may be gradual; validate persistence and highlight incremental gains.
Comorbidity: Address anxiety, trauma, or personality features that maintain chronic mood disturbance.
Interpersonal focus: Explore long-term relational patterns (withdrawal, rejection sensitivity, compliance) that reinforce hopelessness.
Medication adherence: Support collaboration with prescribers, particularly when medication fatigue or skepticism is present.
Relapse prevention: Teach clients to recognize early warning signs and use behavioral or cognitive tools proactively.
Telehealth: Effective for CBT, BA, or MBCT with digital tools for self-monitoring and activity tracking.
References
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.).
Keller, M. B., McCullough, J. P., Klein, D. N., et al. (2000). A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342(20), 1462–1470.
McCullough, J. P. (2003). Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy (CBASP). Guilford Press.
Dimidjian, S., & Davis, K. J. (2022). Behavioral activation for depression: Theoretical updates and clinical implications. Annual Review of Clinical Psychology, 18, 65–91.
Segal, Z. V., Williams, J. M. G., & Teasdale, J. D. (2018). Mindfulness-Based Cognitive Therapy for Depression (2nd ed.). Guilford Press.
Bockting, C. L. H., & Hollon, S. D. (2019). Treatment innovation for persistent depression: The need for integrative cognitive-behavioral approaches. Current Opinion in Psychology, 30, 1–5.
Cuijpers, P., Karyotaki, E., Weitz, E., et al. (2020). The effects of psychotherapies for chronic depression on remission, recovery, and improvement: A meta-analysis. Psychological Medicine, 50(5), 808–819.